Page last updated: 2024-11-05

methyl triflate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9526
CHEMBL ID3185488
SCHEMBL ID38490
MeSH IDM0210325

Synonyms (62)

Synonym
methyl triflate
nsc270679
nsc-270679
333-27-7
methyl trifluoromethanesulfonate
inchi=1/c2h3f3o3s/c1-8-9(6,7)2(3,4)5/h1h
methanesulfonic acid, trifluoro-, methyl ester
methyl trifluoromethanesulfonate, >=98%
ai3-62911
ccris 1158
einecs 206-371-7
nsc 270679
methyl trifluoromethanesulphonate
methyl trifluoromethane sulfonate
T2029
trifluoromethanesulfonic acid methyl ester
AKOS005063680
7b25z22epv ,
methanesulfonic acid, 1,1,1-trifluoro-, methyl ester
unii-7b25z22epv
cas-333-27-7
dtxsid6049272 ,
tox21_202914
dtxcid1029128
NCGC00260460-01
A821727
methyl tris(fluoranyl)methanesulfonate
FT-0628818
methyl triflate;methyl trifluoromethanesulfonate;methyl trifluoromethanesulphonate;trifluoromethanesulfonic acid methyl ester
GC10216
1,1,1-trifluoromethanesulfonic acid methyl ester
methyl trifluoromethanesulfonate [mi]
meotf
c2h3f3o3s
207556-12-5
BP-21280
FD2053
SCHEMBL38490
CS-B0882
methyl trifloromethanesulfonate
methyltriflate
trifluoro-methansulfonic acid methylester
methyltrifluoromethanesulfonate
tfome
trifluoromethylsulfonic acid methyl ester
methyl trifiate
cf3so2och3
methyl trifluoromethylsulfonate
trifluoro-methanesulfonic acid methyl ester
methyl trifluoromethane-sulfonate
methyltrifluoromethane sulfonate
CHEMBL3185488
J-522641
mfcd00000409
methyl trifluoromethanesulfonate, for gc derivatization, 98.0%
J-019144
F1905-7179
BCP22549
AS-18305
Q907614
AMY8849
EN300-62786

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency80.41510.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency14.30010.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency44.71890.003041.611522,387.1992AID1159552; AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency71.67000.000229.305416,493.5996AID1259244
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency64.38510.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency64.38510.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency57.38330.023723.228263.5986AID743222; AID743241
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency64.38510.057821.109761.2679AID1159526
heat shock protein beta-1Homo sapiens (human)Potency62.00670.042027.378961.6448AID743210; AID743228
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency71.67000.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency71.67000.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (28.57)18.2507
2000's8 (28.57)29.6817
2010's12 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.79 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index69.50 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.57%)6.00%
Case Studies1 (3.57%)4.05%
Observational0 (0.00%)0.25%
Other26 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]